A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Mitsubishi Tanabe Pharma Corporation

ClinicalTrials.gov Identifier:

NCT00506441

First received: July 24, 2007

Last updated: February 26, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2009
Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	May 26, 2010